Breakthrough in pancreatic cancer research

Tel Aviv University researchers have discovered that 7% of pancreatic cancer sufferers survive more than five years due to high levels of the gene miR-34a and low levels of the gene PLK1. They then devised a nanoparticle to deliver miR-34a and a PLK1 silencer direct to the tumor.

This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *